Home  |  Contact

Cellosaurus DPX2 (CVCL_UK01)

[Text version]

Cell line name DPX2
Synonyms DPX-2
Accession CVCL_UK01
Resource Identification Initiative To cite this cell line use: DPX2 (RRID:CVCL_UK01)
Comments Biotechnology: Used in cell-based assays for a parallel assessment of CYP3A4 induction, metabolism, and inhibition at the cellular level.
Characteristics: The luciferase reporter gene is under the control of CYP3A4 response elements (proximal promoter and distal xenobiotic-responsive enhancer module).
Transfected with: HGNC; 7968; NR1I2.
Transfected with: UniProtKB; P08659; Firefly luciferase.
Sequence variations NRAS p.Gln61Leu (c.182A>T) (ClinVar=VCV000375874) (from parent cell line).
TERT c.228C>T (-124C>T); in promoter (from parent cell line).
Disease Hepatoblastoma (NCIt: C3728)
Hepatoblastoma (ORDO: Orphanet_449)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0027 (Hep-G2)
Sex of cell Male
Age at sampling 15Y
Category Cancer cell line
Web pages https://www.promegaconnections.com/tag/dpx2-cells/

PubMed=15466163; DOI=10.1124/dmd.104.001594
Yueh M.-F., Kawahara M., Raucy J.L.
High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line.
Drug Metab. Dispos. 33:38-48(2005)

PubMed=22912432; DOI=10.1124/dmd.112.047456
Fahmi O.A., Raucy J.L., Ponce E., Hassanali S., Lasker J.M.
Utility of DPX2 cells for predicting CYP3A induction-mediated drug-drug interactions and associated structure-activity relationships.
Drug Metab. Dispos. 40:2204-2211(2012)

Ontologies CLO; CLO_0037254
Other Wikidata; Q93531270
Entry history
Entry creation25-Feb-2019
Last entry update02-Jul-2020
Version number4